TNFRSF8 and Hodgkins lymphoma: Interestingly, the CD30+ DEV cell line used in this experiment is derived from a case of NLPHL [23], a rare subtype of Hodgkin lymphoma characterized by the presence of lymphocyte predominant (LP) cells.